Episodes
Wednesday Oct 27, 2021
Wednesday Oct 27, 2021
Predictus BioSciences is developing in-vitro diagnostic tests for cancer. Two FDA-approved CPT analogs, topotecan, and irinotecan are used in the tests. The company provides a molecular mechanism of topoI degradation by UPP and identified the molecular determinants of this pathway.
Company Profile Link - https://www.startupsteroid.com/founder?founderUserId=00D76EB1-8533-4DFA-9DD4-3E4AFCD0CC1B
Version: 20240731
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.